O	O	0	9	Decreased	Decrease	B-NP	VBN	O	5	NMOD	O
T8	B-Entity	10	20	proteasome	proteasome	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	20	21	-	-	O	HYPH	O	5	NMOD	O
O	O	21	29	mediated	mediate	B-NP	VBN	O	5	NMOD	O
O	O	30	41	degradation	degradation	I-NP	NN	O	14	NMOD	O
O	O	42	44	in	in	B-PP	IN	O	5	NMOD	O
O	O	45	46	T	T	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	47	52	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	53	57	from	from	B-PP	IN	O	8	NMOD	O
O	O	58	61	the	the	B-NP	DT	O	11	NMOD	O
O	O	62	69	elderly	elderly	I-NP	JJ	O	9	PMOD	O
O	O	69	70	:	:	O	:	O	5	P	O
O	O	71	72	A	A	B-NP	DT	O	14	NMOD	O
O	O	73	77	role	role	I-NP	NN	O	0	ROOT	O
O	O	78	80	in	in	B-PP	IN	O	14	NMOD	O
O	O	81	87	immune	immune	B-NP	JJ	O	17	NMOD	O
O	O	88	98	senescence	senescence	I-NP	NN	O	15	PMOD	O
O	O	98	99	.	.	O	.	O	14	P	O

O	O	101	110	Induction	Induction	B-NP	NN	O	4	SUB	O
O	O	111	113	of	of	B-PP	IN	O	1	NMOD	O
T9	B-Entity	114	122	NFkappaB	NFkappaB	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	123	125	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	126	127	a	a	B-NP	DT	O	8	NMOD	O
O	O	128	134	highly	highly	I-NP	RB	O	7	AMOD	O
O	O	135	144	regulated	regulate	I-NP	VBN	O	8	NMOD	O
O	O	145	152	process	process	I-NP	NN	O	4	PRD	O
O	O	153	162	requiring	require	B-VP	VBG	O	8	NMOD	O
O	O	163	178	phosphorylation	phosphorylation	B-NP	NN	O	18	NMOD	O
O	O	178	179	,	,	O	,	O	18	P	O
O	O	180	194	ubiquitination	ubiquitination	B-NP	NN	O	18	NMOD	O
O	O	194	195	,	,	O	,	O	18	P	O
O	O	196	199	and	and	O	CC	O	18	NMOD	O
T10	B-Entity	200	210	proteasome	proteasome	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	210	211	-	-	O	HYPH	O	15	P	O
O	O	211	219	mediated	mediate	B-NP	VBN	O	18	NMOD	O
O	O	220	231	degradation	degradation	I-NP	NN	O	9	OBJ	O
O	O	232	234	of	of	B-PP	IN	O	18	NMOD	O
O	O	235	238	the	the	B-NP	DT	O	23	NMOD	O
O	O	239	248	cytosolic	cytosolic	I-NP	JJ	B-protein	23	NMOD	B-protein
O	O	249	258	inhibitor	inhibitor	I-NP	NN	I-protein	23	NMOD	I-protein
T1	B-Protein	259	271	IkappaBalpha	IkappaBalpha	I-NP	NN	B-protein	19	PMOD	B-protein
O	O	271	272	.	.	O	.	O	4	P	O

O	O	273	281	Analyses	Analysis	B-NP	NNS	O	20	SUB	O
O	O	282	284	of	of	B-PP	IN	O	1	NMOD	O
O	O	285	288	the	the	B-NP	DT	O	4	NMOD	O
O	O	289	299	regulation	regulation	I-NP	NN	O	2	PMOD	O
O	O	300	302	of	of	B-PP	IN	O	4	NMOD	O
T2	B-Protein	303	315	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	316	318	in	in	B-PP	IN	O	4	NMOD	O
T3	B-Protein	319	322	TNF	TNF	B-NP	NN	B-protein	14	NMOD	B-protein
T3	I-Protein	322	323	-	-	O	HYPH	O	10	P	O
T3	I-Protein	323	328	alpha	alpha	O	SYM	O	14	NMOD	O
O	O	328	329	-	-	O	HYPH	O	14	NMOD	O
O	O	329	336	treated	treat	B-NP	VBN	O	14	NMOD	O
O	O	337	338	T	T	I-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	339	350	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	351	355	from	from	B-PP	IN	O	14	NMOD	O
O	O	356	361	young	young	B-NP	JJ	O	18	AMOD	O
O	O	362	365	and	and	I-NP	CC	O	18	AMOD	O
O	O	366	373	elderly	elderly	I-NP	JJ	O	19	NMOD	O
O	O	374	380	donors	donor	I-NP	NNS	O	15	PMOD	O
O	O	381	389	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	390	398	severely	severely	B-NP	RB	O	22	AMOD	O
O	O	399	410	compromised	compromise	I-NP	VBN	O	23	NMOD	O
O	O	411	422	degradation	degradation	I-NP	NN	O	20	OBJ	O
O	O	423	425	of	of	B-PP	IN	O	23	NMOD	O
T4	B-Protein	426	438	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	24	PMOD	B-protein
O	O	439	441	in	in	B-PP	IN	O	25	NMOD	O
O	O	442	443	T	T	B-NP	NN	B-cell_type	28	NMOD	B-cell_type
O	O	444	449	cells	cell	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	450	454	from	from	B-PP	IN	O	28	NMOD	O
O	O	455	458	the	the	B-NP	DT	O	31	NMOD	O
O	O	459	466	elderly	elderly	I-NP	JJ	O	29	PMOD	O
O	O	466	467	.	.	O	.	O	20	P	O

O	O	468	479	Examination	Examination	B-NP	NN	O	11	SUB	O
O	O	480	482	of	of	B-PP	IN	O	1	NMOD	O
O	O	483	493	activation	activation	B-NP	NN	O	2	PMOD	O
O	O	493	494	-	-	B-NP	HYPH	O	3	NMOD	O
O	O	494	501	induced	induce	I-NP	VBN	O	8	NMOD	O
O	O	502	517	phosphorylation	phosphorylation	I-NP	NN	O	8	NMOD	O
O	O	518	521	and	and	I-NP	CC	O	8	NMOD	O
O	O	522	536	ubiquitination	ubiquitination	I-NP	NN	O	4	PMOD	O
O	O	537	539	of	of	B-PP	IN	O	8	NMOD	O
T5	B-Protein	540	552	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	9	PMOD	B-protein
O	O	553	556	did	do	B-VP	VBD	O	0	ROOT	O
O	O	557	560	not	not	I-VP	RB	O	11	VMOD	O
O	O	561	572	demonstrate	demonstrate	I-VP	VB	O	11	VC	O
O	O	573	576	any	any	B-NP	DT	O	16	NMOD	O
O	O	577	588	significant	significant	I-NP	JJ	O	16	NMOD	O
O	O	589	592	age	age	I-NP	NN	O	19	NMOD	O
O	O	592	593	-	-	B-NP	HYPH	O	16	P	O
O	O	593	600	related	relate	I-NP	VBN	O	19	NMOD	O
O	O	601	612	alterations	alteration	I-NP	NNS	O	13	OBJ	O
O	O	612	613	.	.	O	.	O	11	P	O

O	O	614	621	However	However	B-ADVP	RB	O	15	VMOD	O
O	O	621	622	,	,	O	,	O	15	P	O
O	O	623	634	examination	examination	B-NP	NN	O	15	SUB	O
O	O	635	637	of	of	B-PP	IN	O	3	NMOD	O
T11	B-Entity	638	648	proteasome	proteasome	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	649	657	activity	activity	I-NP	NN	O	4	PMOD	O
O	O	658	660	in	in	B-PP	IN	O	3	NMOD	O
O	O	661	666	these	these	B-NP	DT	O	10	NMOD	O
O	O	667	668	T	T	I-NP	NN	B-cell_type	10	NMOD	B-cell_type
O	O	669	674	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	675	680	using	use	B-VP	VBG	O	3	NMOD	O
O	O	681	692	fluorogenic	fluorogenic	B-NP	JJ	O	14	NMOD	O
O	O	693	700	peptide	peptide	I-NP	NN	O	14	NMOD	O
O	O	701	707	assays	assay	I-NP	NNS	O	11	OBJ	O
O	O	708	716	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	717	718	a	a	B-NP	DT	O	18	NMOD	O
O	O	719	730	significant	significant	I-NP	JJ	O	18	NMOD	O
O	O	731	734	age	age	I-NP	NN	O	15	OBJ	O
O	O	734	735	-	-	B-VP	HYPH	O	18	NMOD	O
O	O	735	742	related	relate	B-NP	VBN	O	21	NMOD	O
O	O	743	750	decline	decline	I-NP	NN	O	19	OBJ	O
O	O	751	753	in	in	B-PP	IN	O	21	NMOD	O
O	O	754	766	chymotryptic	chymotryptic	B-NP	JJ	O	24	NMOD	O
O	O	767	775	activity	activity	I-NP	NN	O	22	PMOD	O
O	O	775	776	.	.	O	.	O	15	P	O

O	O	777	782	These	These	B-NP	DT	O	2	NMOD	O
O	O	783	790	results	result	I-NP	NNS	O	3	SUB	O
O	O	791	798	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	799	803	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	804	805	a	a	B-NP	DT	O	6	NMOD	O
O	O	806	813	decline	decline	I-NP	NN	O	10	SUB	O
O	O	814	816	in	in	B-PP	IN	O	6	NMOD	O
T12	B-Entity	817	827	proteasome	proteasome	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	828	836	activity	activity	I-NP	NN	O	7	PMOD	O
O	O	837	844	results	result	B-VP	VBZ	O	4	SBAR	O
O	O	845	847	in	in	B-PP	IN	O	10	VMOD	O
O	O	848	849	a	a	B-NP	DT	O	13	NMOD	O
O	O	850	857	failure	failure	I-NP	NN	O	11	PMOD	O
O	O	858	860	to	to	B-VP	TO	O	16	VMOD	O
O	O	861	866	fully	fully	I-VP	RB	O	16	VMOD	O
O	O	867	874	degrade	degrade	I-VP	VB	O	13	NMOD	O
T6	B-Protein	875	887	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	16	OBJ	B-protein
O	O	888	890	in	in	B-PP	IN	O	17	NMOD	O
O	O	891	894	the	the	B-NP	DT	O	20	NMOD	O
O	O	895	902	elderly	elderly	I-NP	JJ	O	18	PMOD	O
O	O	902	903	.	.	O	.	O	3	P	O

O	O	904	908	This	This	B-NP	DT	O	2	NMOD	O
O	O	909	916	failure	failure	I-NP	NN	O	6	SUB	O
O	O	917	919	to	to	B-VP	TO	O	4	VMOD	O
O	O	920	927	degrade	degrade	I-VP	VB	O	2	NMOD	O
T7	B-Protein	928	940	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	4	OBJ	B-protein
O	O	941	944	may	may	B-VP	MD	O	0	ROOT	O
O	O	945	953	underlie	underlie	I-VP	VB	O	6	VC	O
O	O	954	958	both	both	O	CC	O	21	NMOD	O
O	O	959	962	the	the	B-NP	DT	O	11	NMOD	O
O	O	963	971	observed	observe	I-NP	VBN	O	11	NMOD	O
O	O	972	980	decrease	decrease	I-NP	NN	O	21	NMOD	O
O	O	981	983	in	in	B-PP	IN	O	11	NMOD	O
T13	B-Entity	984	992	NFkappaB	NFkappaB	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	993	1002	induction	induction	I-NP	NN	O	12	PMOD	O
O	O	1003	1006	and	and	O	CC	O	21	NMOD	O
O	O	1007	1010	the	the	B-NP	DT	O	21	NMOD	O
O	O	1011	1013	IL	IL	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	1013	1014	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
O	O	1014	1015	2	2	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	1016	1024	receptor	receptor	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1025	1035	expression	expression	I-NP	NN	O	7	OBJ	O
O	O	1036	1038	in	in	B-PP	IN	O	21	NMOD	O
O	O	1039	1042	TNF	TNF	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	1042	1043	-	-	B-NP	HYPH	O	27	P	O
O	O	1043	1050	treated	treat	I-NP	VBN	O	27	NMOD	O
O	O	1051	1052	T	T	I-NP	NN	B-cell_type	27	NMOD	B-cell_type
O	O	1053	1058	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	1059	1065	during	during	B-PP	IN	O	7	VMOD	O
O	O	1066	1071	aging	aging	B-NP	NN	O	28	PMOD	O
O	O	1071	1072	.	.	O	.	O	6	P	O

O	O	1073	1077	Thus	Thus	B-ADVP	RB	O	8	VMOD	O
O	O	1077	1078	,	,	O	,	O	8	P	O
O	O	1079	1088	decreased	decrease	B-NP	VBN	O	4	NMOD	O
T14	B-Entity	1089	1099	proteasome	proteasome	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	1099	1100	-	-	O	HYPH	O	7	NMOD	O
O	O	1100	1108	mediated	mediate	B-NP	VBN	O	7	NMOD	O
O	O	1109	1120	degradation	degradation	I-NP	NN	O	8	SUB	O
O	O	1121	1124	may	may	B-VP	MD	O	0	ROOT	O
O	O	1125	1127	be	be	I-VP	VB	O	8	VC	O
O	O	1128	1135	central	central	B-ADJP	JJ	O	9	PRD	O
O	O	1136	1138	to	to	B-PP	TO	O	10	AMOD	O
O	O	1139	1145	immune	immune	B-NP	JJ	O	13	NMOD	O
O	O	1146	1157	dysfunction	dysfunction	I-NP	NN	O	11	PMOD	O
O	O	1158	1162	that	that	B-NP	WDT	O	13	NMOD	O
O	O	1163	1174	accompanies	accompany	B-VP	VBZ	O	14	SBAR	O
O	O	1175	1180	aging	aging	B-NP	NN	O	15	OBJ	O
O	O	1180	1181	.	.	O	.	O	8	P	O

O	O	1182	1191	Copyright	Copyright	B-NP	NN	O	4	NMOD	O
O	O	1192	1196	1999	1999	I-NP	CD	O	4	NMOD	O
O	O	1197	1205	Academic	Academic	I-NP	NNP	O	4	NMOD	O
O	O	1206	1211	Press	Press	I-NP	NNP	O	0	ROOT	O
O	O	1211	1212	.	.	O	.	O	4	P	O
